The role of cystatin C in evaluating the severity and predicting the hospital mortality of patients with community-acquired pneumonia

Ting YANG,Zijian ZENG,Yongchun SHEN,Hao WANG,Chun WAN,Fuqiang WEN

DOI: https://doi.org/10.7507/1002-0179.201710027

2018-01-01

Abstract:Objective To determine the role of serum cystatin C in evaluating the severity and predicting inhospital mortality in patients with community-acquired pneumonia (CAP).Methods The clinical data of 176 patients with CAP treated between January 2015 and October 2016 were collected in a retrospective way.The CURB-65 score was used to assess the severity.The serum levels of cystatin C and C-reactive protein (CRP) on admission were measured.The correlations between cystatin C and CURB-65 score and between cystatin C and CRP were calculated.Receiver operating characteristic curve was used to determine the ability of cystatin C in predicting in-hospital mortality.Results The serum level of cystatin C increased with the increasing CURB-65 score (P＜0.001).The serum level of cystatin C was correlated positively with CRP level (r,=0.190,P＜0.011).There were 22 patients died in hospital,the mean serum cystatin C level of non-survivor was significantly higher than that of survivors [(1.51±0.56) vs.(1.02±0.29) mg/L,P＜0.001].At a cut-off 1.18 mg/L,the sensitivity and specificity of cystatin C in predicting in-hospital mortality were 68.18％ and 81.17％,respectively.The area under the receiver operating characteristic curve was 0.793.The combination of cystatin C and CRP increased the predictive accuracy for in-hospital mortality.Conclusion Cystatin C level increases with the increaseing severity of CAP,and it may be a clinical biomarker to evaluate the severity and prognosis of patients with CAP.